SNCA and synucleinopathy: α-Synuclein (αSyn) aggregates (“strains”) can be detected by seed amplification assays such as real-time quaking-induced conversion from the skin of patients with synucleinopathies including Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA).